Side-by-side financials for DTIL and RVMD. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | DTIL | RVMD |
|---|---|---|
| Market cap | - | $31.73 B |
| US-listed rank | - | #448 |
| Revenue (latest FY) | $34.26M | $0.00 |
| Net income (latest FY) | -$45.72M | -$1.13B |
| Net margin | -133.4% | - |
| SEC filings | 572 | 782 |
In their latest fiscal years, PRECISION BIOSCIENCES INC reported $34.26M in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: PRECISION BIOSCIENCES INC and Revolution Medicines, Inc., or browse the full rankings.